scholarly journals Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice

Metabolism ◽  
2020 ◽  
Vol 113 ◽  
pp. 154352
Author(s):  
Beatriz Merino ◽  
Cristina M. Fernández-Díaz ◽  
Cristina Parrado-Fernández ◽  
Carlos M. González-Casimiro ◽  
Tamara Postigo-Casado ◽  
...  
Keyword(s):  
Obese Mice ◽  
Insulin Degrading Enzyme ◽  
Degrading Enzyme ◽  
Insulin Homeostasis

scholarly journals Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Jean Franciesco Vettorazzi ◽  
Mirian Ayumi Kurauti ◽  
Gabriela Moreira Soares ◽  
Patricia Cristine Borck ◽  
Sandra Mara Ferreira ◽  
...  
Keyword(s):  
Bile Acid ◽  
Insulin Clearance ◽  
Obese Mice ◽  
Insulin Degrading Enzyme ◽  
Degrading Enzyme

scholarly journals Dietary Curcumin Systemically Maintains Insulin Homeostasis in Diet-Induced Aged Obese Mice via Liver-Pancreas-Brain Axis

2021 ◽  
Vol 5 (Supplement_2) ◽  
pp. 29-29
Author(s):  
Yoo Kim ◽  
Caio Henrique Mazucanti ◽  
Jennifer F. O'Connell ◽  
Josephine M. Egan
Keyword(s):  
Insulin Clearance ◽  
Chow Diet ◽  
Obese Mice ◽  
High Fat ◽  
Insulin Degrading Enzyme ◽  
Insulin Levels ◽  
High Sugar ◽  
Insulin Homeostasis ◽  
Normal Chow ◽  
Normal Chow Diet

Abstract Objectives Aging is a condition in which we gradually lose the ability to maintain homeostasis due to dysfunction. There continues to be a knowledge gap in implicating how dietary intervention affects the mechanisms delaying or preventing aging-related chronic diseases. Although curcumin (CUR), a natural antioxidant, shows the putative therapeutic properties such as reinstating insulin homeostasis in obese mice, an aging-associated mechanism in which CUR regulates insulin levels largely remains unclear. Thus, the objective of this study is to determine effects of CUR on anti-aging under obese condition mediated by maintaining insulin homeostasis via cross-talk among liver, pancreas and brain. Methods We examine how dietary CUR improves insulin clearance and maintains a proper range of circulating insulin level in the aged diet-induced obesity (DIO) mouse model. Old male C57BL/6J mice were fed a normal chow diet (NCD) or a NCD containing 0.4% (w/w) curcumin (NCD + CUR), a high fat/high sugar diet (HFHSD) or a HFHSD + CUR (N = 7–9 per group) for 16 weeks. Results Old male C57BL/6J mice were fed a normal chow diet (NCD) or a NCD containing 0.4% (w/w) curcumin (NCD + CUR), a high fat/high sugar diet (HFHSD) or a HFHSD + CUR (N = 7–9 per group) for 16 weeks. Mice given HFHSD + CUR had reduced body weight gain (4.7 ± 1.8 vs 7.8 ± 1.6g) and had lower blood insulin levels (2.24 ± 0.3 vs. 1.53 ± 0.3 ng/ml) under fasting conditions compared to mice on HFHSD alone, resulting from significantly improved insulin clearance via upregulation of hepatic insulin-degrading enzyme (IDE) and circulating IDE levels in serum. On the other hand, the expression of IDE gene in hypothalamus was significantly lower in HFHSD + CUR mice (1.3 folds) than HFHSD animals. Obesity induces hyperglycemic condition in brain by higher IDE expression to excessively break down insulin. We also observed significantly smaller islets of Langerhans (4.53 ± 0.72 vs 7.90 ± 0.34 a.u.) in HFSD + CUR fed mice and increased glucagon contents compared to HFS fed mice, indicating less secretion of insulin in pancreas under obese condition. Conclusions The conclusion of this study is that curcumin is a potent, natural therapeutic agent that can systemically regulate insulin levels in a multifaceted manner to protect against insulin resistance in aged mice. Funding Sources Intramural Research Program of NIAThe OTTOGI HAM TAIHO Foundation

Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis

2018 ◽  
Vol 15 (7) ◽  
pp. 610-617 ◽  
Author(s):  
Huifeng Zhang ◽  
Dan Liu ◽  
Huanhuan Huang ◽  
Yujia Zhao ◽  
Hui Zhou
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Enzyme Activity ◽  
Protein Level ◽  
Senile Plaque ◽  
Meta Analysis ◽  
Cochrane Library ◽  
Insulin Degrading Enzyme ◽  
Degrading Enzyme ◽  
Significant Difference

Background: β-amyloid (Aβ) accumulates abnormally to senile plaque which is the initiator of Alzheimer's disease (AD). As one of the Aβ-degrading enzymes, Insulin-degrading enzyme (IDE) remains controversial for its protein level and activity in Alzheimer's brain. Methods: The electronic databases PubMed, EMBASE, The Cochrane Library, OVID and Sinomed were systemically searched up to Sep. 20th, 2017. And the published case-control or cohort studies were retrieved to perform the meta-analysis. Results: Seven studies for IDE protein level (AD cases = 293; controls = 126), three for mRNA level (AD cases = 138; controls = 81), and three for enzyme activity (AD cases = 123; controls = 75) were pooling together. The IDE protein level was significantly lower in AD cases than in controls (SMD = - 0.47, 95% CI [-0.69, -0.24], p < 0.001), but IDE mRNA and enzyme activity had no significant difference (SMD = 0.02, 95% CI [-0.40, 0.43] and SMD = 0.06, 95% CI [-0.41, 0.53] respectively). Subgroup analyses found that IDE protein level was decreased in both cortex and hippocampus of AD cases (SMD = -0.43, 95% CI [-0.71, -0.16], p = 0.002 and SMD = -0.53, 95% CI [-0.91, -0.15], p = 0.006 respectively). However, IDE mRNA was higher in cortex of AD cases (SMD = 0.71, 95% CI [0.14, 1.29], p = 0.01), not in hippocampus (SMD = -0.26, 95% CI [-0.58, 0.06]). Conclusions: Our results indicate that AD patients may have lower IDE protease level. Further relevant studies are still needed to verify whether IDE is one of the factors affecting Aβ abnormal accumulation and throw new insights for AD detection or therapy.

Sign in / Sign up

Export Citation Format

Share Document